Chronic Treatment with Morphine Disrupts Acute Kinase-Dependent Desensitization of GPCRs

Emily R Leff1, Seksiri Arttamangkul1, John T Williams2

  • 1Vollum Institute, Oregon Health and Science University, Portland, Oregon.

Insights

Chronic morphine disrupts normal desensitization of opioid receptors by altering kinase activity. This leads to a broader reliance on multiple kinases, like protein kinase C and c-Jun N-terminal kinase, for receptor desensitization.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Molecular Biology

Background:

  • Phosphorylation of the µ-opioid receptor (MOR) is crucial for acute desensitization and tolerance.
  • Understanding the specific kinases involved in MOR desensitization is essential for therapeutic development.

Purpose of the Study:

  • To identify the kinases mediating MOR desensitization in brain slices from naive and morphine-treated animals.
  • To investigate the impact of chronic morphine treatment on kinase-dependent G protein-coupled receptor (GPCR) desensitization.

Main Methods:

  • Whole-cell recordings from locus coeruleus neurons to measure agonist-induced potassium conductance.
  • Pharmacological inhibition of G-protein receptor kinase (GRK2/3), protein kinase C, and c-Jun N-terminal kinase.
  • Assessment of receptor internalization and desensitization of both MOR and somatostatin receptors.

Main Results:

  • In naive animals, GRK2/3 inhibition blocked acute MOR desensitization and receptor internalization.
  • Chronic morphine treatment reduced the effectiveness of GRK2/3 inhibition alone, requiring additional kinase inhibitors (PKC, JNK) to block desensitization.
  • Similar disruptions in kinase-dependent desensitization were observed for the somatostatin receptor following chronic morphine treatment.

Conclusions:

  • Chronic morphine induces heterologous adaptations in kinase regulation of GPCR desensitization.
  • While GRK2/3 mediates acute desensitization in naive states, chronic morphine recruits additional kinases (PKC, JNK) for this process.
  • These findings reveal a complex interplay of kinases in GPCR regulation following prolonged opioid exposure.

Related Concept Videos

GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
7.7K
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.4K
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
2.9K
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
3.7K
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
749
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
813